Craig Swearingen

622 citations

21 papers · 423 indexed · h-index 15

Co-authors: Kannan Thirunavukkarasu Gary DeCrescenzo Grace E. Munie M.G. Chambers Susan L. Hockerman Daniel P. Becker John N. Freskos Daniel P. Getman
Topics: Peptidase Inhibition and Analysis (6 papers)Protease and Inhibitor Mechanisms (6 papers)Osteoarthritis Treatment and Mechanisms (5 papers)
Cited by: Rheumatology Cancer Research Immunology and Allergy
Journals: Journal of Medicinal Chemistry Journal of Lipid Research Clinical Orthopaedics and Related Research
Partner nations: United States Canada Australia

In The Last Decade

Craig Swearingen

21 papers receiving 409 citations

Peers

Countries citing papers authored by Craig Swearingen

Since Specialization

Citations

This map shows the geographic impact of Craig Swearingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Swearingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Swearingen more than expected).

Fields of papers citing papers by Craig Swearingen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Swearingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Swearingen. The network helps show where Craig Swearingen may publish in the future.

Co-authorship network of co-authors of Craig Swearingen

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Swearingen. A scholar is included among the top collaborators of Craig Swearingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Swearingen. Craig Swearingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Measuring Lp(a) particles with a novel isoform-insensitive immunoassay illustrates efficacy of muvalaplin 2024 ·Journal of Lipid Research ·Craig Swearingen,John H. Sloan,(unknown),Robert W. Siegel,Nicoletta Bivi,Yuewei Qian,Robert J. Konrad,Michael B. Boffa,Marlys L. Koschinsky,John H. Krege,Giacomo Ruotolo,Stephen J. Nicholls,Laura F. Michael,Yi Wen	3
2	A Monovalent Fab Affinity-Capture and Elution Bridging Immunoassay Overcomes Rheumatoid Factor Interference while Accurately Detecting Antidrug Antibodies 2023 ·The Journal of Applied Laboratory Medicine ·Boris Calderón,(unknown),Craig Swearingen,(unknown),Nicoletta Bivi,(unknown),(unknown),Robert W. Siegel,Robert J. Konrad	1
3	Development and validation of a novel immunogenicity assay to detect anti-drug and anti-PEG antibodies simultaneously with high sensitivity 2020 ·Journal of Immunological Methods ·Nicoletta Bivi,Craig Swearingen,(unknown),John H. Sloan,(unknown),(unknown),Michael E. Hodsdon,Robert W. Siegel,Robert J. Konrad	8
4	Investigation of pre-existing reactivity to biotherapeutics can uncover potential immunogenic epitopes and predict immunogenicity risk 2019 ·mAbs ·Nicoletta Bivi,Terry L. Moore,George H. Rodgers,(unknown),(unknown),Craig Swearingen,Valentina Gelfanova,Boris Calderón,Daniel A. Peterson,Michael E. Hodsdon,Robert W. Siegel,Richard E. Higgs,Robert J. Konrad	19
5	A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose 2017 ·Journal of Medicinal Chemistry ·Timothy B. Durham,(unknown),(unknown),Chin Liu,(unknown),Daniel R. Mudra,Craig Swearingen,Chaohua Lin,M.G. Chambers,Kannan Thirunavukkarasu,Michael R. Wiley	12
6	Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis 2016 ·Journal of Pharmacology and Experimental Therapeutics ·Kannan Thirunavukkarasu,Bo Tan,Craig Swearingen,Guilherme Rocha,Huynh‐Hoa Bui,Denis McCann,Shawn B. Jones,Bryan H. Norman,(unknown),J. K. Saha	25
7	Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain 2016 ·Osteoarthritis and Cartilage ·Kannan Thirunavukkarasu,Craig Swearingen,J.L. Oskins,Chaohua Lin,Hong‐Thuy Bui,Spencer B. Jones,(unknown),Bryan H. Norman,(unknown),M.G. Chambers	16
8	Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design 2016 ·ACS Medicinal Chemistry Letters ·Spencer B. Jones,Lance A. Pfeifer,Thomas J. Bleisch,Thomas J. Beauchamp,Jim D. Durbin,Valentine J. Klimkowski,(unknown),Christopher J. Rito,(unknown),Joseph M. Gruber,Hai H. Bui,M.G. Chambers,Srinivasan Chandrasekhar,Chaohua Lin,Denis McCann,Daniel R. Mudra,J.L. Oskins,Craig Swearingen,Kannan Thirunavukkarasu,Bryan H. Norman	39
9	Intraarticular Matrix Metalloproteinases and Aggrecan Degradation Are Elevated After Articular Fracture 2015 ·Clinical Orthopaedics and Related Research ·Justin M. Haller,Craig Swearingen,(unknown),Molly McFadden,Kannan Thirunavukkarasu,Thomas F. Higgins	25
10	Identification of Potent and Selective Hydantoin Inhibitors of Aggrecanase-1 and Aggrecanase-2 That Are Efficacious in Both Chemical and Surgical Models of Osteoarthritis 2014 ·Journal of Medicinal Chemistry ·Timothy B. Durham,Valentine J. Klimkowski,Christopher J. Rito,(unknown),(unknown),Chin Liu,Jim D. Durbin,Stephanie L. Stout,(unknown),Craig Swearingen,Chaohua Lin,M.G. Chambers,Kannan Thirunavukkarasu,Michael R. Wiley	21
11	A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs 2010 ·Osteoarthritis and Cartilage ·Craig Swearingen,M.G. Chambers,Chaohua Lin,(unknown),Christopher J. Rito,(unknown),Joe E. Dotzlaf,(unknown),S. Chandrasekhar,Kevin L. Duffin,Peter G. Mitchell,Timothy B. Durham,Michael R. Wiley,Kannan Thirunavukkarasu	21
12	MMP-13 selective isonipecotamide α-sulfone hydroxamates 2010 ·Bioorganic & Medicinal Chemistry Letters ·Stephen A. Kolodziej,Susan L. Hockerman,Gary DeCrescenzo,Joseph J. McDonald,(unknown),Grace E. Munie,Theresa Fletcher,(unknown),Craig Swearingen,Daniel P. Becker	22
13	Development of a novel clinical biomarker assay to detect and quantify aggrecanase-generated aggrecan fragments in human synovial fluid, serum and urine 2010 ·Osteoarthritis and Cartilage ·Craig Swearingen,John W. Carpenter,Robert W. Siegel,Isabelle J. Brittain,Joe E. Dotzlaf,Timothy B. Durham,(unknown),Dennis A. Laska,(unknown),(unknown),(unknown),(unknown),Michael R. Wiley,Kevin L. Duffin,Peter G. Mitchell,Kannan Thirunavukkarasu	33
14	Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective α-sulfone hydroxamates 2010 ·Bioorganic & Medicinal Chemistry Letters ·Stephen A. Kolodziej,Susan L. Hockerman,Terri L. Boehm,(unknown),Gary DeCrescenzo,Joseph J. McDonald,(unknown),Grace E. Munie,Theresa Fletcher,Joseph G. Rico,(unknown),Craig Swearingen,Daniel P. Becker	15
15	Development and characterization of a novel ELISA based assay for the quantitation of sub-nanomolar levels of neoepitope exposed NITEGE-containing aggrecan fragments 2007 ·Journal of Immunological Methods ·(unknown),Joe E. Dotzlaf,Craig Swearingen,Isabelle J. Brittain,M.G. Chambers,Kevin L. Duffin,Peter G. Mitchell,Kannan Thirunavukkarasu	14
16	Synthesis and Structure−Activity Relationships of β- and α-Piperidine Sulfone Hydroxamic Acid Matrix Metalloproteinase Inhibitors with Oral Antitumor Efficacy 2005 ·Journal of Medicinal Chemistry ·Daniel P. Becker,Clara I. Villamil,Thomas E. Barta,Louis J. Bedell,Terri L. Boehm,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,R. Heintz,Susan C. Howard,(unknown),Joseph J. McDonald,(unknown),(unknown),Pramod P. Mehta,Grace E. Munie,Craig Swearingen	51
17	α-Amino-β-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1 2001 ·Bioorganic & Medicinal Chemistry Letters ·Daniel P. Becker,Thomas E. Barta,Louis J. Bedell,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,(unknown),Pramod P. Mehta,(unknown),Grace E. Munie,Craig Swearingen,Clara I. Villamil	27
18	α-Alkyl-α-amino-β-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1 2001 ·Bioorganic & Medicinal Chemistry Letters ·Daniel P. Becker,Gary DeCrescenzo,John N. Freskos,Daniel P. Getman,Susan L. Hockerman,(unknown),Pramod P. Mehta,Grace E. Munie,Craig Swearingen	19
19	Discovery of a novel series of selective MMP inhibitors: Identification of the γ-sulfone-thiols 1999 ·Bioorganic & Medicinal Chemistry Letters ·John N. Freskos,(unknown),Gary DeCrescenzo,R. Heintz,Daniel P. Getman,Susan C. Howard,Nandini Kishore,Joseph J. McDonald,Grace E. Munie,Shaukat H. Rangwala,Craig Swearingen,Charles F. Voliva,Dean J. Welsch	21
20	Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB10401 1995 ·Arthritis & Rheumatism* ·Susan L. Woulfe,Christine P. Bono,(unknown),Dawn A. Kirschmann,Troy A. Baudino,Craig Swearingen,Robert W. Karr,Benjamin D. Schwartz	26

About Craig Swearingen

Craig Swearingen is a scholar working on Cancer Research, Rheumatology and Immunology and Allergy, having authored 21 papers that have together received 423 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Protease and Inhibitor Mechanisms (6 papers) and Osteoarthritis Treatment and Mechanisms (5 papers). The work is most often cited by research in Rheumatology (113 citations), Cancer Research (107 citations) and Immunology and Allergy (25 citations). Craig Swearingen has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Kannan Thirunavukkarasu, Gary DeCrescenzo, Grace E. Munie, M.G. Chambers, Susan L. Hockerman, Daniel P. Becker, John N. Freskos, Daniel P. Getman, Joseph J. McDonald and Chaohua Lin. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Lipid Research and Clinical Orthopaedics and Related Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact